Groundbreaking research reveals how certain gut cells can be transformed into insulin-producing cells, offering new hope for Type 1 diabetes treatment and potentially revolutionising diabetes care.
Former Pennsylvania nurse Heather Pressdee faces multiple murder charges after allegedly administering lethal insulin doses to numerous patients across multiple care facilities.
Millions of Britons are walking around with prediabetes without knowing it. Discover the subtle symptoms and lifestyle changes that could prevent Type 2 diabetes.
New research reveals how normal-weight individuals can develop type 2 diabetes due to poor metabolic health, challenging conventional wisdom about weight and wellness.
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Groundbreaking research reveals how a specific gene disrupts insulin production in the pancreas, offering new hope for millions living with diabetes worldwide.
A family's terrifying ordeal after a diabetic emergency leads to accidental use of wrong medication. Exclusive interview reveals how common medical devices caused dangerous confusion.
A leading weight loss expert explains how hormone imbalances could be preventing you from losing weight, and shares the simple signs to watch for.
Families across England face a devastating postcode lottery as NHS refuses to fund essential glucose monitors for children with Type 1 diabetes, forcing desperate parents to crowdfund for basic medical care.
An ITV doctor exposes the hidden medical conditions, from hormone imbalances to medication side-effects, that can sabotage weight loss, and explains when to see your GP.
Groundbreaking UK research discovers that a natural compound in the common curry spice, turmeric, could revolutionise the management of type 2 diabetes and support healthy weight loss, offering a new dietary supplement strategy.
The NHS has finally approved a groundbreaking artificial pancreas system for Type 1 diabetes patients following years of campaigning by families and charities.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.